OBJECT Earlier "studies have indicated that the equilibrium of the plasminplasmin inhibitor system in blood can be shifted under various experimental conditions {1,2,3,4). The present study is concerned 1 with this system as influenced by cortisone, adrenocorticotropin, thyroxine and thyrotropin and by splenectomy, adrenaiectomy, and hypophysectomy.
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The results obtained seem to substantiate the concept that the observed increased antifibrinolytic activity i=s a result of an actual increase in the plasmin inhibitor in the blood ratheT than a result of an acceleration of the rate of combination between plasmin and plasmin. inhibitor.
RECOMMENDATIONS
The role of the spleen in maintaining the equilibrium between plasmin and plasmin inhibitor in blood should be studied. 1,2,3,4) . The present study is concerned with the plasmin -plasmin inhibitor system as influenced by cortisone, adrenpcorticotropin, thyroxine and thyrotrppin, and by splenectbmy, adrenalectomy, and hypophysectomy. According to Ungar and his associates (4,5) the action of certain endocrine principles on the antifibrinolytic activity of serum, appears to result in an acceleration of the rate of combination of plasmin and plasmin inhibitor and not in ah actual increase in the plasmin inhibitor. However, the findings presented in this report do not seem to substantiate this concept.
II. EXPERIMENTAL
Male Sprague -Dawley albino rats weighing 220-250 grams were used. The animals were allowed food and water throughout the experiment. Unless noted all injections were given subcutaireously* Normal controls received no injections, while injected controls received a volume of solvent equal to that used in the hormone injections.
Splenectbmy was performed on fasting rats anesthetized by ether. Animals regained their normal weight within the second or third post-operative day. The experimental work was carried out 7 days after splenectomy.
Hypophyse ctomized and adrenalectomized rats were obtained from the Hormone Assay Laboratories, Inc. , Chicago, Illinois.
The hormones were injected subcutaneously and the following preparations and dosages were used: Adrenpcorticoteopin,. Armour A-ctha-r^-^equivalent to 1. 0 nig Standard LA-1-A/kg twice daily for 3 days; controls -equivalent volume of Q. 9% saline.
Cortisone, Merck Cor tone Acetate, 5 mg/kg daily for 3 days; cpntrols -equivalent volume of Q. 9% saline;
Thyroxine, Squibb Crystalline Thyrpxihe, 0. 5 mg/kg daily for 4 days; controls, -equivalent volume of slightly alkaline 0. 9% saline.
.: _ JL Thyrotropin*, Armour Lot 2 ^D-3, LJW3-16-48 containing 5 Junkman -Schoeiler units permg, 10 mg/kg daily for 5 days; controls -equivalent volume of slightly alkaline 0. 9% saline.
Blood samples, 1.8 ml, were taken by heart puncture 2 hours after the last injection, using 0. 2 ml of 3. 8% sodium citrate as the anticoagulant. Following centrifugation at 2800 rpm for 30 minutes at. 5 to iÖ°C, the plasma was separated and analyzed immediately or stored frozen until tested.
The äntifibrinolytic activity of plasma was determined by measuring the residual activity of s-standard amount (2 mg**) of bovine plasmin***, after incubation for 5 and 30 minutes with a 4% concentration of the plasma to be tested, as previously described (1). Thrombin, salt-free, (Parke -Davis) andfibrinogenprepared according to Ware, Guest, and Seegers (6) were used. Calculations of antifibrinolytic units were performed as previously reported (7).
The plasmin inhibitor preparation used in these studies was obtained by (NH4) 2SO4 fractionation of ä product prepared from bovine plasma according to Loomis, Ryder, and George (8) . When tested against standard trypsin, it was found that 60 gamma of this preparation were equivalent to 1 antifibrinolytic unit.
in. RESULTS AND DISCUSSION
In substantiation of earlier observations by Christensen and MacLeod (9) and by Lewis and Ferguson (10) , it was found that the inhibition of plasmin required a higher concentration of plasmin inhibitor than is necessary to produce the same percentage, of inhibition with trypsin, of equal fibrinolytic potency. In agreement with Christensen and (MacLeod (9), it also was found that the kinetics of plasmin and trypsin in the presence of plasmin inhibitor were quite distinct. The experimental data of these observations have been omitted since they merely substantiate the findings of the above investigators.
:
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The rate of combination between plasmin and its inhibitor was dependent on the time of incubation, of the reäctants; a 30 minute incubation produced a greater inhibition than did the 5 minute incubation, both in the case of rat plasma and a purified preparation of bovine plasmin inhibitor (Tables I and II) . These findings are in agreement with similar observations reported by Guest, Daly, Ware, andSeegers (11) . It was found that the inhibition of trypsin by normal rat plasma after 30 minutes incubation was somewhat greater than after 5 minutes incubation, but the difference was not as pronounced as that observed with plasmin. The antifibrinolytic activity of plasma-of nominal rats after 5 minutes incubation was 88 4-8 units and after 30 minutes, 106+-6-units (Table  III) . The plasmas of control rats injected either with saline or alkaline saline had similar antifibrinolytic activities. The injection of adrenocorticotropin (2 mg/kg subcutaneously daily in 2 divided injections (4 hrs. apart) for 3 days) in normal rats produced an increase in the antifibrinolytic activity of the blood, as measured after 5 or 30 minutes incubation; 101 + 12 and 119 + 8 units, respectively, (Table III) . Thyrotropin, given for~5 days>, produced similar though less striking results., Cortisone and thyroxine, administered for 3 and 4 days, respectively, produced a slight elevation of the antifibrinolytic activity which was evident only after 30 minutes incubation. .q2 Single intraperitoneal injections of adrenocorticotropin ( 1 to 4 mg per rat) 1 , of adrenal cortical extract (2 to 4 ml per. rat), or of thyroxine (1 mg per rat) were found to produce no significant change in the plasrnin inhibitor titer 15 to 90 minutes after administration.
'o'he antifibrinolytic activity of plasma 10 days after removal of the hypophysis or of the adrenals was found to be greatly reduced (Table III) . Splenectömy did not alter the plasrnin inhibitor level of plasma (Table III,) ., In splenectomized rats, adrenocorticotropin administration (same procedure as in normal animals) did not produce any change in the antifibrinolytic activity of the blood, as measured after 5 or 30 minutes incubation (Table III) . Apparently, the influence of the adrenals on the plasrnin inhibitor titer is mediated through the spleen. In this connection it may be pointed out that Macfarlane and Biggs (12) have observed that among all the organs, extracts of the spleen had the highest antifibrinolytic activity.
On the other hand, administration of thyroxine (same procedure as iii nocmal animals) to the splenectomized rat was found to produce a slight elevation of the antifibrinolytic titer after 30'minutes incubation (Table III) . Apparently, more than one mechanism is responsible for the control of the plasrnin inhibitor level in blood.
In general, these findings ar/e iii agreement with Ungar's (4,5) •observations of.an increased antifibrinolytic activity after, administration of adrenocorticotropin to normal animals and of no alteration in the plasrnin inhibitor titer when administered to splenectomized animals. However* the results presented do not seem to substantiate the concept suggested by Ungar (4, 5) that adrenocorticotropin effects the antifibrinolytic activity of plasma by accelerating the rate of combination between plasrnin and : plasmin inhibitor, rather than by increasing; the plasrnin inhibitor. Instead, the recorded data tend to show that the observed increased antifibrinolytic activity is ä result of an actual rise of the plasrnin inhibitor in the blood. However, it :should be pointed out that the observed increase in antifibrinolytic activity may also be due to a decrease in fibrinolytic activity. The test employed did not t>ake into account a decrease or increase; in fibrinolytic activity, which is always rn^r"ke.d by the excess piä'sHnin over plaämin for plasminogen) in normal blood.
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IV. SUMMARY
The degree of combination between plasrnin and plasrnin inhibitor was found to depend on the incubation ;time of the reactants. Administration of adrenpeörticotropin produced a definite increase in antifibrinoiytic activity of blood. The injection of cortisone, thyroxine, or thyrotrppih caused a slight elevation of the plasmin inhibitor in blood.
The antifibrinoiytic activity of plasma of fats s 30 days after removal of the hypophysis or of the adrenals* was found to be greatly reduced. Splenectomy did not alter the plasmin inhibitor level of plasma. In splehectomized rats, adrenocorticotrppin administration did not pro> duce any change in the antifibrinoiytic activity of the blood. On the other hand, administration of thyroxine to splenectomized rats was found to produce-ä slight elevation of the antifibrinoiytic titer.
The role of the spleen in maintaining; the. equilibrium between plasmin y and plasmin inhibitor in blood should be studied. 
